On April 30, 2018 Pfenex Inc. (NYSE American: PFNX) reported that its first quarter 2018 financial results will be released on Thursday, May 10, 2018, after the market close (Press release, Pfenex, APR 30, 2018, View Source/2018-04-30-Pfenex-to-Report-First-Quarter-2018-Results-and-Provide-Business-Update-on-Thursday-May-10th" target="_blank" title="View Source/2018-04-30-Pfenex-to-Report-First-Quarter-2018-Results-and-Provide-Business-Update-on-Thursday-May-10th" rel="nofollow">View Source [SID1234525856]). Pfenex management will host a corresponding conference call and a live webcast at 4:30 pm ET/1:30 pm PT on the same day to discuss the financial results and provide a business update.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Thursday, May 10, 2018 @ 4:30 pm Eastern Time/1:30 pm Pacific Time
US Toll Free:
866-376-8058
International:
412-542-4131
Access Code:
10120009
Webcast:
www.pfenex.com
A replay of the call will be available through May 17th:
US Toll Free:
877-344-7529
International:
412-317-0088
Replay Access Code:
10120009
Webcast:
www.pfenex.com
Pfenex investors and others should note that we announce material information to the public about the Company through a variety of means, including our website (View Source), our investor relations website (View Source), press releases, SEC filings, public conference calls, corporate Twitter account (View Source), Facebook page (View Source), and LinkedIn page (View Source) in order to achieve broad, non-exclusionary distribution of information to the public and to comply with our disclosure obligations under Regulation FD. We encourage our investors and others to monitor and review the information we make public in these locations as such information could be deemed to be material information. Please note that this list may be updated from time to time